Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.
Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A. Tournigand C, et al. Among authors: couteau c. J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2. J Clin Oncol. 2004. PMID: 14657227 Corrected and republished. Clinical Trial.
[Adenocarcinoma of the pancreas. Diagnosis and evaluation].
André T, Balosso J, Louvet C, Gligorov J, Couteau C, Avenin D, de Gramont A, Izrael V. André T, et al. Among authors: couteau c. Presse Med. 1998 Mar 21;27(11):537-8. Presse Med. 1998. PMID: 9767969 French.
CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.
André T, Louvet C, Maindrault-Goebel F, Couteau C, Mabro M, Lotz JP, Gilles-Amar V, Krulik M, Carola E, Izrael V, de Gramont A. André T, et al. Among authors: couteau c. Eur J Cancer. 1999 Sep;35(9):1343-7. doi: 10.1016/s0959-8049(99)00150-1. Eur J Cancer. 1999. PMID: 10658525 Clinical Trial.
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.
Douillard JY, Gervais R, Dabouis G, Le Groumellec A, D'Arlhac M, Spaeth D, Coudert B, Caillaud D, Monnier A, Clary C, Maury B, Mornet M, Rivière A, Clouet P, Couteau C. Douillard JY, et al. Among authors: couteau c. Ann Oncol. 2005 Jan;16(1):81-9. doi: 10.1093/annonc/mdi013. Ann Oncol. 2005. PMID: 15598943 Free article. Clinical Trial.
Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A, Fandi A, Azli N, Wibault P, Chouaki N, Hasbini A, Couteau C, Armand JP, Cvitkovic E. Taamma A, et al. Among authors: couteau c. Cancer. 1999 Oct 1;86(7):1101-8. doi: 10.1002/(sici)1097-0142(19991001)86:7<1101::aid-cncr2>3.0.co;2-r. Cancer. 1999. PMID: 10506692 Clinical Trial.
CPT-11. The European experience.
Armand JP, Terret C, Couteau C, Rixe O. Armand JP, et al. Among authors: couteau c. Ann N Y Acad Sci. 1996 Dec 13;803:282-91. doi: 10.1111/j.1749-6632.1996.tb26398.x. Ann N Y Acad Sci. 1996. PMID: 8993522 Review.
121 results